Inventor · disambiguated record
Roberto Pellicciari
Also filed as: PELLICCIARI ROBERTO
67 granted patents·23 pending applications·707 citations·filing 1983–2025
99Inventor score
Files withINTERCEPT PHARMACEUTICALS INC42PELLICCIARI ROBERTO16TES PHARMA S R L9GIULIANI SPA6GIPHARMEX SPA3
Top patents by PatentIndex Score
90 records- 0197US9611289B2Farnesoid X receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2014·Granted Apr 4, 2017·13 cites·20 claims
- 0296US10532061B2Farnesoid X receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2018·Granted Jan 14, 2020·5 cites·6 claims
- 0396US9763964B2Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditionsINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted Sep 19, 2017·23 cites·7 claims
- 0495US7786102B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2006·Granted Aug 31, 2010·20 cites·3 claims
- 0595US7138390B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS·Filed 2002·Granted Nov 21, 2006·73 cites·11 claims
- 0694US8377916B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2011·Granted Feb 19, 2013·15 cites·4 claims
- 0794US7932244B2Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditionsINTERCEPT PHARMACEUTICALS INC·Filed 2007·Granted Apr 26, 2011·24 cites·8 claims
- 0893US8114862B2TGR5 modulators and methods of use thereofPELLICCIARI ROBERTO·Filed 2009·Granted Feb 14, 2012·13 cites·9 claims
- 0992US7858608B2Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditionsINTERCEPT PHARMACEUTICALS INC·Filed 2009·Granted Dec 28, 2010·21 cites·5 claims
- 1092US7812011B2Steroid agonist for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2005·Granted Oct 12, 2010·18 cites·11 claims
- 1191US8796249B2TGR5 modulators and methods of use thereofPELLICCIARI ROBERTO·Filed 2009·Granted Aug 5, 2014·13 cites·21 claims
- 1291US8058267B2Steroids as agonists for FXRPELLICCIARI ROBERTO·Filed 2009·Granted Nov 15, 2011·8 cites·5 claims
- 1391US7994352B2Process for preparing 3a(β)-7a(β)-dihydroxy-6a(β)-alkyl-5β-cholanic acidINTERCEPT PHARMACEUTICALS INC·Filed 2006·Granted Aug 9, 2011·22 cites·39 claims
- 1491US7825129B2Thieno[2,3-c] isoquinolines for use as inhibitors of PARPPELLICCIARI ROBERTO·Filed 2005·Granted Nov 2, 2010·19 cites·31 claims
- 1590US8445472B2TGR5 modulators and methods of use thereofPELLICCIARI ROBERTO·Filed 2011·Granted May 21, 2013·9 cites·11 claims
- 1690US6989388B2Thieno[2,3-c]iosquinolines for use as inhibitors of PARPPELLICCIARI ROBERTO·Filed 2001·Granted Jan 24, 2006·37 cites·17 claims
- 1789US8546365B2Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditionsPELLICCIARI ROBERTO·Filed 2011·Granted Oct 1, 2013·10 cites·18 claims
- 1889US8410083B223-substituted bile acids as TGR5 modulators and methods of use thereofPELLICCIARI ROBERTO·Filed 2008·Granted Apr 2, 2013·9 cites·19 claims
- 1989US4892868ADerivatives of biliary acids, process for the production thereof and corresponding pharmaceutical compositionsGIPHARMEX SPA·Filed 1986·Granted Jan 9, 1990·52 cites·15 claims
- 2088US4921848ABiliary acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing themGIPHARMEX SPA·Filed 1988·Granted May 1, 1990·39 cites·5 claims
- 2188US2024398834A1Farnesoid x receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2287US11345721B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2020·Granted May 31, 2022·2 cites·6 claims
- 2387US10800807B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Oct 13, 2020·3 cites·17 claims
- 2487US9732117B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Aug 15, 2017·3 cites·10 claims
- 2586US5061701AFluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing themGIULIANI SPA·Filed 1990·Granted Oct 29, 1991·58 cites·4 claims
- 2686US2023233581A1Farnesoid x receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2785US5175320AFluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing themGIULIANI SPA·Filed 1991·Granted Dec 29, 1992·39 cites·1 claims
- 2884US9777038B2Process for preparing bile acid derivativesINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Oct 3, 2017·3 cites·6 claims
- 2984US9650409B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted May 16, 2017·4 cites·8 claims
- 3084US9498484B2Treatment of fibrosis using FXR ligandsFIORUCCI STEFANO·Filed 2005·Granted Nov 22, 2016·8 cites·8 claims
- 3184US9243027B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Jan 26, 2016·5 cites·17 claims
- 3284US8999964B2TGR5 modulators and methods of use thereofPELLICCIARI ROBERTO·Filed 2009·Granted Apr 7, 2015·6 cites·17 claims
- 3383US11034717B2Farnesoid X receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Jun 15, 2021·3 cites·10 claims
- 3482US10815267B23-desoxy derivative and pharmaceutical compositions thereofINTERCEPT PHARMACEUTICALS INC·Filed 2017·Granted Oct 27, 2020·1 cites·4 claims
- 3582US9540414B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2014·Granted Jan 10, 2017·4 cites·2 claims
- 3682US4514393ANew derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the sameLEHNER AG·Filed 1983·Granted Apr 30, 1985·27 cites·14 claims
- 3781US11000532B2Farnesoid x receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2019·Granted May 11, 2021·0 cites·16 claims
- 3881US10421772B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2017·Granted Sep 24, 2019·1 cites·8 claims
- 3981US9708272B2Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylaseTES PHARMA S R L·Filed 2015·Granted Jul 18, 2017·4 cites·13 claims
- 4081US9090652B2Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditionsINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Jul 28, 2015·3 cites·9 claims
- 4181US8969330B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Mar 3, 2015·2 cites·7 claims
- 4280US11066437B2Methods and intermediates for the preparation of bile acid derivativesINTERCEPT PHARMACEUTICALS INC·Filed 2018·Granted Jul 20, 2021·2 cites·22 claims
- 4380US8299090B2Thiazolyl-and oxazolyl-isoquinolinones and methods for using themPELLICCIARI ROBERTO·Filed 2009·Granted Oct 30, 2012·3 cites·16 claims
- 4479US2025376488A1Farnesoid x receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4577US11254644B2Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylaseTES PHARMA S R L·Filed 2019·Granted Feb 22, 2022·1 cites·17 claims
- 4677US7718815B2Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disordersNEWRON PHARM SPA·Filed 2005·Granted May 18, 2010·4 cites·3 claims
- 4777US2021228599A1Farnesoid x receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4875US12291549B2Farnesoid X receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2021·Granted May 6, 2025·0 cites·2 claims
- 4973US5057509ABile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing themGIULIANI SPA·Filed 1990·Granted Oct 15, 1991·26 cites·4 claims
- 5072US8906935B2Thiazolyl- and oxazolyl-isoquinolinones and methods for using themPELLICCIARI ROBERTO·Filed 2012·Granted Dec 9, 2014·2 cites·15 claims
Showing the top 50 of 90 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →